Citrullinaemia type I: a common mutation in the Pacific Island population

Emma Glamuzina1, Renate Marquis-Nicholson, Detlef Knoll

  • 1Paediatric Metabolic Service, Starship Children's Hospital, Auckland, New Zealand.

Insights

A new ASS1 gene mutation screening protocol helps diagnose citrullinaemia type I in neonates. This method confirms diagnosis and predicts disease severity, identifying a common mutation in Pacific Island populations.

Area of Science:

  • Biochemistry
  • Genetics
  • Newborn Screening

Background:

  • Expanded newborn screening (E-NBS) identifies neonates with elevated citrulline.
  • Citrullinaemia type I diagnosis requires confirmation, often through genetic analysis.
  • The ASS1 gene is crucial for urea cycle function and citrulline metabolism.

Purpose of the Study:

  • To develop and implement a mutation screening protocol for the ASS1 gene.
  • To confirm diagnoses of citrullinaemia type I in neonates identified by E-NBS.
  • To correlate ASS1 gene mutations with clinical presentation and disease severity.

Main Methods:

  • Identified three neonates with elevated citrulline via E-NBS.
  • Applied polymerase chain reaction (PCR) and sequencing to analyze the ASS1 gene.
  • Utilized a rapid mutation-specific detection method and followed clinical progress.

Main Results:

  • All three patients were homozygous for the missense mutation c.787G>A (p.Val263Met) in the ASS1 gene.
  • This mutation is associated with a mild or asymptomatic clinical course.
  • The same mutation was found in all patients, irrespective of non-consanguinity or Pacific Island origin.

Conclusions:

  • Rapid ASS1 gene sequencing confirms citrullinaemia type I and helps infer phenotypic severity in screened neonates.
  • The identified mutation (c.787G>A) may be prevalent in specific ethnic groups, suggesting a possible founder effect.
  • This protocol aids in managing neonates with elevated citrulline detected through E-NBS.
Abstract

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Mutations01:39

Mutations

Overview
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...